The Effect of Infliximab on Patients with Ulcerative Colitis in Korea

BACKGROUND/AIMS: Infliximab was introduced recently as a rescue therapy for ulcerative colitis (UC) patients refractory to conventional treatments such as therapy with 5-amiono salicylic acids (5-ASA), immune modulators, and corticosteroids. However, there is insufficient data about its efficacy and...

Descripción completa

Detalles Bibliográficos
Autores principales: Seo, Hyun Il, Park, Dong Il, Kim, Tae Oh, Kim, You Sun, Lee, Suck-Ho, Kim, Ji Won, Kim, Jae Hak, Shin, Jeong Eun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Association for the Study of Intestinal Diseases 2014
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4204725/
https://www.ncbi.nlm.nih.gov/pubmed/25349595
http://dx.doi.org/10.5217/ir.2014.12.3.214

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4204725/
https://www.ncbi.nlm.nih.gov/pubmed/25349595
http://dx.doi.org/10.5217/ir.2014.12.3.214

Ejemplares similares